TREM2 and frontotemporal dementia: A missense mutation in the gene expressing triggering receptor expressed on myeloid cells 2 (TREM2) was found to be a significant risk factor not only for AD (Jonsson et al., 2013) but for frontotemporal dementia and PD as well (Rayaprolu et al., 2013).